<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To quantitate plasma <z:chebi fb="7" ids="17761">ceramide</z:chebi> subspecies concentrations in <z:mp ids='MP_0001261'>obese</z:mp> subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and relate these plasma levels to the severity of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="7" ids="17761">Ceramides</z:chebi> are a putative mediator of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and lipotoxicity, and accumulation of <z:chebi fb="7" ids="17761">ceramides</z:chebi> within tissues in <z:mp ids='MP_0001261'>obese</z:mp> and diabetic subjects has been well described </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: We analyzed fasting plasma <z:chebi fb="7" ids="17761">ceramide</z:chebi> subspecies by quantitative tandem mass spectrometry in 13 <z:mp ids='MP_0001261'>obese</z:mp> type 2 diabetic patients and 14 lean healthy control subjects </plain></SENT>
<SENT sid="3" pm="."><plain>Results were related to insulin sensitivity measured with the hyperinsulinemic-euglycemic clamp technique and with plasma <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-alpha) levels, a marker of <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="7" ids="17761">Ceramide</z:chebi> species (C18:1, 18:0, 20:0, 24:1, and 24:0) were quantified using electrospray ionization tandem mass spectrometry after separation with high-performance liquid chromatography </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Insulin sensitivity (mg x kg(-1) x min(-1)) was lower in type 2 diabetic patients (4.90 +/- 0.3) versus control subjects (9.6 +/- 0.4) (P &lt; 0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>Type 2 diabetic subjects had higher (P &lt; 0.05) concentrations of <z:chebi fb="0" ids="28842">C18:0</z:chebi>, C20:0, C24:1, and total <z:chebi fb="7" ids="17761">ceramide</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Insulin sensitivity was inversely correlated with <z:chebi fb="0" ids="28842">C18:0</z:chebi>, C20:0, C24:1, C24:0, and total <z:chebi fb="7" ids="17761">ceramide</z:chebi> (<z:hpo ids='HP_0000001'>all</z:hpo> P &lt; 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>Plasma TNF-alpha concentration was increased (P &lt; 0.05) in type 2 diabetic subjects and correlated with increased C18:1 and <z:chebi fb="0" ids="28842">C18:0</z:chebi> <z:chebi fb="7" ids="17761">ceramide</z:chebi> subspecies </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Plasma <z:chebi fb="7" ids="17761">ceramide</z:chebi> levels are elevated in type 2 diabetic subjects and may contribute to <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> through activation of <z:mp ids='MP_0002501'>inflammatory mediators</z:mp>, such as TNF-alpha </plain></SENT>
</text></document>